Published:
Medistem Laboratories to Present at the University of Latvia's International Conference on Stem Cells and Cell Therapy
Medistem Laboratories (OTCBB: MDSM)
announced today that Thomas Ichim, Chief of Scientific Development, will
present at an International stem cell conference being put on by the
University of Latvia on November 2, 2007. Ichim's talk will address recent
results from Medistem's basic research and pre-clinical activities
surrounding the Tolerostem and Angiostem platforms.
About Medistem Laboratories, Inc.
Medistem Laboratories is a biotechnology company that discovers, develops,
and commercializes adult stem cell products that address serious medical
conditions. While drug discovery and development is its primary focus,
Medistem has compiled a body of proprietary technologies it outlicenses to
commercial entities in markets where stem cell administration is
permissible. Due to its licensee relationships and collaborative efforts
with respected institutions, Medistem believes it is well positioned to be
a leading developer of adult stem cell products.
Copyright © 2009, MarketWire
Copyright © 2009, NewsBlaze,
Daily NewsTags: ,Medical and Healthcare:HealthandNutrition, MedicalandHealthcare:Healthcare, MedicalandHealthcare:SurgeryandTreatments, PharmaceuticalsandBiotech:Biotech, PharmaceuticalsandBiotech:Drugs, PharmaceuticalsandBiotech:Trials, ,OTCBULLB,OTCBULLB,AZ,SCOTTSDALE, AZ
Search News
Daily News
